Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2020 | 3 |
2021 | 3 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Adjuvant Chemotherapy for Stage II Colon Cancer.
Cancers (Basel). 2020 Sep 10;12(9):2584. doi: 10.3390/cancers12092584.
Cancers (Basel). 2020.
PMID: 32927771
Free PMC article.
Review.
Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes.
Roesel R, Deantonio L, Bernardi L, Garo ML, Majno-Hurst P, Vannelli A, Cefalì M, Palmarocchi MC, Valli MC, Pesola G, Cristaudi A, De Dosso S.
Roesel R, et al. Among authors: pesola g.
Cancers (Basel). 2023 Sep 19;15(18):4627. doi: 10.3390/cancers15184627.
Cancers (Basel). 2023.
PMID: 37760596
Free PMC article.
Review.
Item in Clipboard
Combined response of advanced cutaneous squamous cell carcinoma and renal cell carcinoma to immunotherapy: a case report.
Murianni V, Cerbone L, Rescigno P, Catalano F, Damassi A, Cremante M, Gandini A, Puglisi S, Pesola G, Banna GL, Buti S, Signori A, Fornarini G, Rebuzzi SE.
Murianni V, et al. Among authors: pesola g.
Immunotherapy. 2022 Dec;14(18):1419-1427. doi: 10.2217/imt-2022-0150. Epub 2023 Jan 4.
Immunotherapy. 2022.
PMID: 36597723
Review.
Item in Clipboard
Durable response after immunotherapy discontinuation for delayed and severe immune-related adverse events: a case report.
Pesola G, Murianni V, Rebuzzi SE, Banna GL, Cerbone L, Catalano F, Borea R, Gandini A, Cremante M, Puglisi S, Trovato F, Fornarini G.
Pesola G, et al.
Immunotherapy. 2021 Dec;13(17):1379-1386. doi: 10.2217/imt-2021-0085. Epub 2021 Nov 8.
Immunotherapy. 2021.
PMID: 34743545
Item in Clipboard
Outstanding Response in a Patient With ROS1-Rearranged Inflammatory Myofibroblastic Tumor of Soft Tissues Treated With Crizotinib: Case Report.
Comandini D, Catalano F, Grassi M, Pesola G, Bertulli R, Guadagno A, Spina B, Mascherini M, De Cian F, Pistoia F, Rebuzzi SE.
Comandini D, et al. Among authors: pesola g.
Front Oncol. 2021 Jun 15;11:658327. doi: 10.3389/fonc.2021.658327. eCollection 2021.
Front Oncol. 2021.
PMID: 34211840
Free PMC article.
Item in Clipboard
The prognostic value of CD3+ tumor-infiltrating lymphocytes for stage II colon cancer according to use of adjuvant chemotherapy: A large single-institution cohort study.
Francini E, Ou FS, Lazzi S, Petrioli R, Multari AG, Pesola G, Messuti L, Colombo E, Livellara V, Bazzurri S, Cherri S, Miano ST, Wolfe EG, Alberts SR, Hubbard JM, Yoon HH, Francini G.
Francini E, et al. Among authors: pesola g.
Transl Oncol. 2021 Feb;14(2):100973. doi: 10.1016/j.tranon.2020.100973. Epub 2020 Dec 15.
Transl Oncol. 2021.
PMID: 33338878
Free PMC article.
Item in Clipboard
Gemcitabine plus nab-paclitaxel followed by maintenance treatment with gemcitabine alone as first-line treatment for older adults with locally advanced or metastatic pancreatic cancer.
Petrioli R, Torre P, Pesola G, Paganini G, Paolelli L, Miano ST, Martellucci I, Francini G, Francini E.
Petrioli R, et al. Among authors: pesola g.
J Geriatr Oncol. 2020 May;11(4):647-651. doi: 10.1016/j.jgo.2019.08.008. Epub 2019 Aug 27.
J Geriatr Oncol. 2020.
PMID: 31471168
Item in Clipboard
Cite
Cite